Melatonin for Prevention of Metabolic Side Effects of Olanzapine
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether melatonin can prevent metabolic side
effects of olanzapine such as weight gain, elevated glucose concentrations and lipid
abnormalities.